EchoNous vs icometrix
Kosmos is a handheld ultrasound probe carried to the patient. icobrain is software that measures brain MRI scans a hospital has already taken. EchoNous sells to clinicians who scan, icometrix to services that read MRI.
An emergency, cardiology or oncology team buys Kosmos for automated ejection fraction, AI FAST view labeling and bladder volume at the bedside. The vendor says Kosmos Plus costs under $20k, currency not stated, with a five year warranty, and other configurations are quoted. Four Kosmos 510(k)s run from March 2020 to April 2025.
A neurology or neuroradiology service buys icobrain to track multiple sclerosis, dementia or amyloid-therapy patients across serial MRI. K240712, cleared in November 2024, is the vendor's ARIA-E and ARIA-H detection module, and the vendor lists CPT III codes 0865T and 0866T. icometrix lists no public price, only a contact route. GE HealthCare announced the acquisition in September 2025 and says it intends distribution on all vendors' MRI systems.
Radiology · Reviewed November 2, 2026
When to pick each one
EchoNous
- Handheld ultrasound with AI ejection fraction and FAST
- Kosmos Plus under $20k per vendor, currency not stated
- Four Kosmos 510(k)s from 2020 to 2025
icometrix
- Brain MRI volumetry for MS, dementia and ARIA
- Vendor lists CPT III codes 0865T and 0866T
- Now a GE HealthCare company per its site
Score
Each row shows points earned of points available under the published rubric.
EchoNous
78of 100
icometrix
68of 100
| Dimension | EchoNous | icometrix | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 10 / 10 | 0 / 10 | +10 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 18.2 / 18.2 | 18.2 / 18.2 | 0 |
| RCT / meta-analysis / systematic review | 7.8 / 7.8 | 3.9 / 7.8 | +3.9 |
| Funding & adoption signal | 3 / 12 | 8.4 / 12 | -5.4 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 6 / 6 | 6 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
EchoNous
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. The vendor says Kosmos Plus costs less than $20k. |
icometrix
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
EchoNous
FDA decisions
K242321 (opens in new tab)510(k)2025-04-25
Kosmos
K233826 (opens in new tab)510(k)2024-08-29
Kosmos
K212100 (opens in new tab)510(k)2021-08-06
Kosmos
K193518 (opens in new tab)510(k)2020-03-26
KOSMOS
Peer-reviewed
5 PubMed records name EchoNous.
- Army Medic Performance in Trauma Sonography: The Impact of Artificial Intelligence Assistance in Focused Assessments With Sonography in Trauma-A Prospective Randomized Controlled Trial. (opens in new tab)
- Point-of-care AI-enhanced novice echocardiography for screening heart failure (PANES-HF). (opens in new tab)
- Validation of a hand-held ultrasound device in the evaluation of aortic stenosis. (opens in new tab)
icometrix
FDA decisions
K240712 (opens in new tab)510(k)2024-11-07
icobrain aria
K192962 (opens in new tab)510(k)2020-02-28
icobrain-ctp
K192130 (opens in new tab)510(k)2019-12-13
Icobrain
K181939 (opens in new tab)510(k)2018-11-06
icobrain
K180326 (opens in new tab)510(k)2018-03-08
icobrain
Show 1 more
K161148 (opens in new tab)510(k)2016-08-09
icobrain
Peer-reviewed
5 PubMed records name icometrix.
- Lecanemab in practice: AI-derived MRI predictors of benefit and Amyloid Related Imaging Abnormalities (ARIA). (opens in new tab)
- Uncovering heterogeneous cognitive trajectories in relapsing-remitting multiple sclerosis: a longitudinal study. (opens in new tab)
- Quantifying White Matter Hyperintensities: Automated Volumetry Compared with Visual Grading Scales. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | EchoNous | icometrix |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | 2016 | 2011 |
| HQ | US | BE |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.


